We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI-Based Algorithm Improves Accuracy of Breast Cancer Diagnoses

By MedImaging International staff writers
Posted on 26 Aug 2024
Print article
Image: The image illustrates the gradient-based saliency maps predicted by the MV-DEFEAT model (Photo courtesy of University of Eastern Finland)
Image: The image illustrates the gradient-based saliency maps predicted by the MV-DEFEAT model (Photo courtesy of University of Eastern Finland)

High breast tissue density is known to raise the risk of breast cancer, and its measurement can be derived from mammograms. Accurate interpretation of mammograms is vital for successful breast cancer screening but is hampered by inconsistencies in radiological evaluations and a worldwide shortage of radiologists. To overcome these challenges, a new artificial intelligence (AI)-based algorithm uses deep learning to analyze multiple mammogram views concurrently, simulating the evaluation process of radiologists.

The MV-DEFEAT algorithm, developed by researchers at the University of Eastern Finland (Kuopio, Finland), improves the assessment of mammogram density, potentially revolutionizing radiological procedures by facilitating more accurate diagnoses. The research team applied a multi-view deep evidential fusion approach, incorporating aspects of the Dempster-Shafer evidential theory and subjective logic to provide a thorough analysis of mammogram images from various angles. MV-DEFEAT significantly outperforms existing methods, increasing the precision of mammogram screenings by effectively and consistently determining the density and distribution of dense breast tissue. Specifically, in the public VinDr-Mammo dataset, which contains over 10,000 mammograms, the algorithm achieved a 50.78% improvement in differentiating between benign and malignant tumors compared to previous multi-view approaches. Additionally, MV-DEFEAT generates gradient-based saliency maps that accentuate critical areas, aiding radiologists in their diagnostic decisions.

The algorithm's effectiveness across various datasets highlights its ability to accommodate diverse patient demographics. It was tested using data from four open-source datasets, which broadened its accuracy and generalizability. These features underscore the potential of AI-driven methods in medical diagnostics. Although MV-DEFEAT significantly supports breast cancer screening, the researchers stress the need for ongoing enhancement and validation to confirm its dependability and effectiveness in clinical environments. This progress represents a critical step toward integrating AI in diagnostic procedures, which may lead to earlier detection and improved outcomes for breast cancer patients.

“To fully integrate AI like MV-DEFEAT into clinical practice, it is crucial to build trust among healthcare professionals through rigorous testing and validation,” said Doctoral Researcher Raju Gudhe of the University of Eastern Finland. “Indeed, our next steps involve further validation studies to establish MV-DEFEAT as a reliable tool for breast cancer diagnostics in Finland.”

Related Links:
University of Eastern Finland

Silver Member
Radiographic Positioning Equipment
2-Step Multiview Positioning Platform
New
Digital X-Ray Detector Panel
Acuity G4
Portable Color Doppler Ultrasound System
S5000
New
Mini C-arm Imaging System
Fluoroscan InSight FD

Print article

Channels

Ultrasound

view channel
Image: The novel method of fighting cancer can stimulate critical cytokine secretion in T cells

Ultrasound-Directed Microbubbles Boost Immune Response Against Tumors

A significant challenge in cancer treatment is the tumor's ability to suppress the immune system, particularly by deactivating T cells that enter the tumor. Once inside, the tumor can inhibit T cells from... Read more

Nuclear Medicine

view channel
Image: PSMA-PET/CT images of an 85-year-old patient with hormone-sensitive prostate cancer (Photo courtesy of Dr. Adrien Holzgreve)

Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients

Prostate-specific membrane antigen–positron emission tomography (PSMA-PET) imaging has become an essential tool in transforming the way prostate cancer is staged. Using small amounts of radioactive “tracers,”... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.